|
S.N. Tolpygina
Possibility of high-selective adrenoblockers use in combined therapy ofpatients with metabolic syndrome
|
№4 / 2018
|
|
S.V. Levchenko, I.A. Komissarenko
Estimation of hypolipidemic psillium effect in gastroenterologic patients with lipid metabolism disorders
|
№2 / 2018
|
|
O.A. Gromova, I.Ju. Torshin, Zh.D. Kobalava, M.A. Sorokina
About fundamental and clinical aspects of magnesium and ribolavine synergic action in therapeutic practice
|
№1 / 2018
|
|
А.M. Kаrdаngushevа, Z.A. Shugushevа, I.KH. Bekulovа, N.M. Bekaidieva
Prevalence of some managed risk factors of cardiovascular diseases among young students
|
№6 / 2017
|
|
T.Yu. Demidova, Ya.V. Pugovkina
Type 2 diabetes mellitus and cardiovascular diseases. Therapy that changes prognosis
|
№5 / 2017
|
|
Ye.A. Yermakova, I.I. Kochergina
Features of course of arterial hypertension in patients with type 2 diabetes mellitus, its role in the development of vascular complications
|
№5 / 2017
|
|
V.B. Mychka, E.I. Uzueva
Cardiovascular diseases at the prehospital stage: how to improve the effectiveness of care?
|
№1 / 2015
|
Русский
